We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current 0JZU market cap is 20.07B. The company's latest EPS is USD 25.9854 and P/E is 20.41.
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 214.32B | 231.05B | 238.23B | 263.97B | 276.72B |
| Operating Income | 791M | 1.38B | -4.98B | 2.18B | 4.39B |
| Net Income | 34M | 900M | -4.54B | 1.11B | 3.56B |
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 59.67B | 61.25B | 65.02B | 63.3B | 62.32B |
| Total Liabilities | 49.99B | 54.54B | 63.57B | 65.09B | 63.81B |
| Total Equity | 8.29B | 5.31B | 175M | -1.79B | -1.49B |
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 4.04B | 4.37B | 4.54B | 4.43B | 5.16B |
| Investing | -1.38B | -579M | -415M | -89M | -542M |
| Financing | -2.23B | -2.73B | -1.69B | -6.32B | -4.37B |
| Market Cap | 20.07B |
| Price to Earnings Ratio | 20.41 |
| Price to Sales Ratio | 0.26 |
| Price to Cash Ratio | 15.53 |
| Price to Book Ratio | -48.76 |
| Dividend Yield | - |
| Shares Outstanding | 137M |
| Average Volume (1 week) | 257 |
| Average Volume (1 Month) | 352 |
| 52 Week Change | 0.00% |
| 52 Week High | 146.50 |
| 52 Week Low | 146.50 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Mckesson Corp |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.mckesson.com |
| Industry | drugs and proprietary-whsl (5122) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
